# Aggamin Pharmaceuticals, LLC — Form D

Aggamin Pharmaceuticals, LLC of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-04-18. The offering totals $3.7M, of which $3.7M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2013-04-18
- Form: D
- Accession: 0001574522-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $3.7M
- Amount sold: $3.7M
- Investors: 7
- Date of first sale: 2013-03-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-195212

## Issuer

- Name: Aggamin Pharmaceuticals, LLC
- CIK: 0001574522
- Entity type: Limited Liability Company
- Jurisdiction: MASSACHUSETTS
- Incorporated: 2009
- Address: 11 BYRON STREET, BOSTON, MA, 02108
- Phone: 212-568-4614

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| John DT Gerber | Director | Washington, DC |
| Subbian Ananth Karumanchi | Director | Boston, MA |
| Paul Kussie | Director | Boston, MA |
| Vikas P Sukhatme | Director | Boston, MA |
| Ravi Ishwar Thadhani | Director | Boston, MA |

## More

- [CIK 1574522 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1574522&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001574522-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.